• Legal information
  • Site Map
BG logo blue
  • Home
  • Services
    • Our transactions
    • Investment Banking
      • Private Placements
      • Public Offerings
      • M&A for private companies
      • M&A for public companies
    • Capital Markets
      • Equity Research
      • Institutional Sales
      • Derivatives Sales & Trading
      • Corporate Research
    • Equity Research login
  • Sectors
    • Technology
    • Healthcare
    • Consumer
    • Business Services
  • Intelligence
  • Events
  • About us
    • About us
    • Senior team
  • Careers
    • Healthcare opportunities
    • Investment Banking positions
    • Equity Sales & Research positions
    • Current Support Team Offerings
    • Internship offerings
  • Contact us
    • Contact Us
    • Senior Team
  • Search
  • Legal information
  • Site Map

Public Offerings

Nicox_website_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering

Voltalia_website_tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Proparco on its EUR 23 million Secondary Offering of Voltalia shares

Abivax_website_tombstone

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Abivax on its EUR 28 million Follow-on Offering

Tombstone_gensight

Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering

Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering

McPhy_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies

website_tombstone_2

Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors

tombstone_humanigen_78200000_dollars

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering

Azelio tombstone 2

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 270 million Follow-on Offering

BioNTech_website_tombstone

Bryan, Garnier & Co acts as Co-manager to BioNTech on its USD511.5 million upsized Publicly-marketed Follow-on Offering

  • 1
  • 2
  • 3
  • …
  • 9
Menu

Home

All transactions

Investment Banking

Capital Markets

Sectors

Intelligence

Other

Events

Our team

Careers

About us

Contact us

Legal

  • Legal information
  • Site Map

Latest News

  • Meal kit: Dinner is served!
  • Bryan, Garnier & Co is delighted to announce the appointment of Clifford Siegel as Non-Executive Chairman
  • Game-changing technologies to meet the climate challenge
  • Climate tech
  • SaaS: the virtuous circle of subscriptions
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Privacy Preference Center

Privacy Preferences